{"id":"W4402050123","doi":"10.1093/eurheartj/ehae613","title":"Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Astellas Pharma; European Commission; Sanofi; Bayer HealthCare; McMaster University; Gilead Sciences; Novo Nordisk; Steno Diabetes Center Copenhagen; Intas Pharmaceuticals; Eli Lilly and Company; AstraZeneca; Bayer; Pfizer","keywords":"Semaglutide; Medicine; Type 2 diabetes; Kidney disease; Diabetes mellitus; Internal medicine; Disease; Cardiology; Intensive care medicine; Endocrinology; Liraglutide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009248832,0.0001450891,0.0003340569,0.0000924173,0.00005673781,0.00006298298,0.00009367976,0.00001210484,0.0001514312],"category_scores_gemma":[0.0000953852,0.00007772423,0.0002976077,0.0002177644,0.00006101958,0.00006970835,0.00004808031,0.0002696337,0.00007326339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009165377,"about_ca_system_score_gemma":0.0001949778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004291534,"about_ca_topic_score_gemma":0.000001163127,"domain_scores_codex":[0.9986898,0.0002654663,0.0002305068,0.0001743864,0.0003892874,0.0002506119],"domain_scores_gemma":[0.9993279,0.00004556271,0.00003225297,0.0003219065,0.00003373699,0.0002386519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006516212,0.001387675,0.4102205,0.001197505,0.009253269,0.003675645,0.0006847946,0.001033255,0.0002309102,0.00004869713,0.4982163,0.06753524],"study_design_scores_gemma":[0.02299606,0.001823214,0.1772425,0.001184107,0.001618161,0.0000278283,0.00004006128,0.001515628,0.00008270879,0.00002029805,0.7932267,0.0002226895],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9692838,0.02110315,0.0000455625,0.00502827,0.0009186094,0.0007654338,0.00002099087,0.00005860879,0.002775585],"genre_scores_gemma":[0.9966252,0.0003922296,0.0001407222,0.0006239208,0.0004857766,0.000005818667,0.00001782791,0.00004410586,0.00166437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2950104,"threshold_uncertainty_score":0.3169502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01714606731619368,"score_gpt":0.2567611198266074,"score_spread":0.2396150525104137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}